136 related articles for article (PubMed ID: 34697649)
1. Sarcopenia at the infrahyoid level as a prognostic factor in patients with advanced-stage non-virus-related head and neck carcinoma.
Yunaiyama D; Okubo M; Arizono E; Tsukahara K; Tanigawa M; Nagao T; Saito K
Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3131-3137. PubMed ID: 34697649
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma.
Erul E; Guven DC; Ozbay Y; Altunbulak AY; Kahvecioglu A; Ercan F; Yesil MF; Ucdal MT; Cengiz M; Yazici G; Kuscu O; Suslu N; Gullu I; Onur MR; Aksoy S
Biomark Med; 2023 Jan; 17(2):87-99. PubMed ID: 37042459
[TBL] [Abstract][Full Text] [Related]
6. The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy.
Bentahila R; Giraud P; Decazes P; Kreps S; Nay P; Chatain A; Fabiano E; Durdux C
Cancer Med; 2023 Feb; 12(4):4170-4183. PubMed ID: 36263581
[TBL] [Abstract][Full Text] [Related]
7. Low skeletal muscle mass as predictor of postoperative complications and decreased overall survival in locally advanced head and neck squamous cell carcinoma: the role of ultrasound of rectus femoris muscle.
Galli A; Colombo M; Carrara G; Lira Luce F; Paesano PL; Giordano L; Bondi S; Tulli M; Mirabile A; De Cobelli F; Bussi M
Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3489-3502. PubMed ID: 32535862
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index.
Lu X; Tian Y; Huang J; Li F; Shao T; Huang G; Lv X
Oral Dis; 2023 Apr; 29(3):923-932. PubMed ID: 34773352
[TBL] [Abstract][Full Text] [Related]
9. Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy.
van Rijn-Dekker MI; van den Bosch L; van den Hoek JGM; Bijl HP; van Aken ESM; van der Hoorn A; Oosting SF; Halmos GB; Witjes MJH; van der Laan HP; Langendijk JA; Steenbakkers RJHM
Radiother Oncol; 2020 Jun; 147():103-110. PubMed ID: 32251949
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous cell carcinoma: A retrospective single-center study.
Bonavolontà P; Improta G; Dell'Aversana Orabona G; Goglia F; Abbate V; Sorrentino A; Piloni S; Salzano G; Iaconetta G; Califano L
J Craniomaxillofac Surg; 2023 Jan; 51(1):7-15. PubMed ID: 36739189
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia with inflammation as a predictor of survival in patients with head and neck cancer.
Yamahara K; Mizukoshi A; Lee K; Ikegami S
Auris Nasus Larynx; 2021 Oct; 48(5):1013-1022. PubMed ID: 33883097
[TBL] [Abstract][Full Text] [Related]
12. Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia During Chemoradiotherapy.
Endo K; Ueno T; Hirai N; Komori T; Nakanishi Y; Kondo S; Wakisaka N; Yoshizaki T
Laryngoscope; 2021 May; 131(5):E1524-E1529. PubMed ID: 33030229
[TBL] [Abstract][Full Text] [Related]
13. The impact of skeletal muscle depletion on older adult patients with head and neck cancer undergoing primary surgery.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
J Geriatr Oncol; 2021 Jan; 12(1):128-133. PubMed ID: 32565144
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia predicts a poor treatment outcome in patients with head and neck squamous cell carcinoma receiving concurrent chemoradiotherapy.
Shodo R; Yamazaki K; Ueki Y; Takahashi T; Horii A
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):2001-2009. PubMed ID: 32772234
[TBL] [Abstract][Full Text] [Related]
15. Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma.
Roberti E; Merlano M; Ravanelli M; Alberti A; Esposito A; Gili R; Spinazzé S; Baré C; Jocollé G; Benasso M; Bertolotti F; Vecchio S; Bacigalupo A; Licitra L; Denaro N; Damico M; Lorini L; Gurizzan C; Alfieri S; Bossi P
Oral Oncol; 2023 Oct; 145():106540. PubMed ID: 37567147
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
17. The use of the second thoracic vertebral landmark for skeletal muscle assessment and computed tomography-defined sarcopenia evaluation in patients with head and neck cancer.
Vangelov B; Bauer J; Moses D; Smee R
Head Neck; 2023 Apr; 45(4):1006-1016. PubMed ID: 36811256
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
Yoon JK; Jang JY; An YS; Lee SJ
PLoS One; 2021; 16(7):e0254844. PubMed ID: 34280248
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer.
Ye Z; Saraf A; Ravipati Y; Hoebers F; Catalano PJ; Zha Y; Zapaishchykova A; Likitlersuang J; Guthier C; Tishler RB; Schoenfeld JD; Margalit DN; Haddad RI; Mak RH; Naser M; Wahid KA; Sahlsten J; Jaskari J; Kaski K; Mäkitie AA; Fuller CD; Aerts HJWL; Kann BH
JAMA Netw Open; 2023 Aug; 6(8):e2328280. PubMed ID: 37561460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
